| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 10473 | 2021 |
| Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021 | 3188 | 2021 |
| The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries AP Ambrosy, GC Fonarow, J Butler, O Chioncel, SJ Greene, ... Journal of the American College of Cardiology 63 (12), 1123-1133, 2014 | 2406 | 2014 |
| Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... New England Journal of Medicine 381 (17), 1609-1620, 2019 | 1899 | 2019 |
| Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology … B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ... Journal of cardiac failure 27 (4), 387-413, 2021 | 1679 | 2021 |
| How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the … B Pieske, C Tschöpe, RA De Boer, AG Fraser, SD Anker, E Donal, ... European heart journal 40 (40), 3297-3317, 2019 | 1544 | 2019 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ... New England Journal of Medicine 387 (12), 1089-1098, 2022 | 1457 | 2022 |
| Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study CSP Lam, VL Roger, RJ Rodeheffer, BA Borlaug, FT Enders, MM Redfield Journal of the American College of Cardiology 53 (13), 1119-1126, 2009 | 1215 | 2009 |
| Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction BA Borlaug, RA Nishimura, P Sorajja, CSP Lam, MM Redfield Circulation: Heart Failure 3 (5), 588-595, 2010 | 1121 | 2010 |
| Vericiguat in patients with heart failure and reduced ejection fraction PW Armstrong, B Pieske, KJ Anstrom, J Ezekowitz, AF Hernandez, ... New England Journal of Medicine 382 (20), 1883-1893, 2020 | 1098 | 2020 |
| Epidemiology and clinical course of heart failure with preserved ejection fraction CSP Lam, E Donal, E Kraigher‐Krainer, RS Vasan European journal of heart failure 13 (1), 18-28, 2011 | 972 | 2011 |
| Cardiac structure and ventricular–vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota CSP Lam, VL Roger, RJ Rodeheffer, F Bursi, BA Borlaug, SR Ommen, ... Circulation 115 (15), 1982-1990, 2007 | 867* | 2007 |
| Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction BA Borlaug, TP Olson, CSP Lam, KS Flood, A Lerman, BD Johnson, ... Journal of the American College of Cardiology 56 (11), 845-854, 2010 | 834 | 2010 |
| The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 B Vogel, M Acevedo, Y Appelman, CNB Merz, A Chieffo, GA Figtree, ... The Lancet 397 (10292), 2385-2438, 2021 | 824 | 2021 |
| Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, ... The lancet Diabetes & endocrinology 9 (10), 653-662, 2021 | 690 | 2021 |
| Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction RJ Mentz, JP Kelly, TG von Lueder, AA Voors, CSP Lam, MR Cowie, ... Journal of the American College of Cardiology 64 (21), 2281-2293, 2014 | 614 | 2014 |
| 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European Heart Journal 44 (37), 3627-3639, 2023 | 609 | 2023 |
| Sex differences in heart failure CSP Lam, C Arnott, AL Beale, C Chandramouli, D Hilfiker-Kleiner, ... European heart journal 40 (47), 3859-3868c, 2019 | 576 | 2019 |
| SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials M Vaduganathan, KF Docherty, BL Claggett, PS Jhund, RA de Boer, ... The Lancet 400 (10354), 757-767, 2022 | 535 | 2022 |
| Contractility and ventricular systolic stiffening in hypertensive heart disease: insights into the pathogenesis of heart failure with preserved ejection fraction BA Borlaug, CSP Lam, VL Roger, RJ Rodeheffer, MM Redfield Journal of the American College of Cardiology 54 (5), 410-418, 2009 | 518 | 2009 |
